World Investment Advisors Acquires 3,973 Shares of iShares Biotechnology ETF $IBB

World Investment Advisors grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 50.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,853 shares of the financial services provider’s stock after buying an additional 3,973 shares during the quarter. World Investment Advisors’ holdings in iShares Biotechnology ETF were worth $2,000,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Dynamic Wealth Strategies LLC grew its stake in shares of iShares Biotechnology ETF by 16.6% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after buying an additional 60 shares during the last quarter. Flagship Private Wealth LLC grew its stake in shares of iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after buying an additional 60 shares during the last quarter. Webster Bank N. A. grew its stake in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after buying an additional 62 shares during the last quarter. Choreo LLC grew its stake in iShares Biotechnology ETF by 2.2% in the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after purchasing an additional 65 shares in the last quarter. Finally, HB Wealth Management LLC grew its stake in iShares Biotechnology ETF by 1.4% in the fourth quarter. HB Wealth Management LLC now owns 4,699 shares of the financial services provider’s stock worth $793,000 after purchasing an additional 66 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $166.83 on Friday. iShares Biotechnology ETF has a 52-week low of $118.51 and a 52-week high of $179.64. The business’s 50 day moving average is $169.24 and its 200 day moving average is $169.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.